Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Price:
3.53
USD
-0.28%
Market Cap:
$575.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
US |
|
N
|
Nam Kim Steel JSC
VN:NKG
|
VN |
|
H
|
Haiha Confectionery JSC
VN:HHC
|
VN |
|
Fielmann AG
XETRA:FIE
|
DE |
|
And Factory Inc
TSE:7035
|
JP |
|
F
|
First Foundation Inc
F:8F1
|
US |
|
B
|
Bombardier Inc
TSX:BBD.A
|
CA |
|
F
|
Forge Global Holdings Inc
NYSE:FRGE
|
US |
|
Japan Airlines Co Ltd
TSE:9201
|
JP |
|
Tintra PLC
LSE:TNT
|
UK |
|
ARSS Infrastructure Projects Ltd
NSE:ARSSINFRA
|
IN |
|
Tokyo Kiho Co Ltd
TSE:7597
|
JP |
|
S
|
Sumasapo Inc
TSE:9342
|
JP |
|
Redflow Ltd
ASX:RFX
|
AU |
Multiples-Based Value
The Multiples-Based Value of one
IRWD
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.53 USD,
Ironwood Pharmaceuticals Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IRWD Multiples-Based Value
LOCKED
Multiples Across Competitors
IRWD Competitors Multiples
Ironwood Pharmaceuticals Inc Competitors
Ironwood Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
575.6m USD | 1.9 | 24 | 6.2 | 6.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 5.8 | 85.3 | 14.2 | 19.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 4.9 | 23.6 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9 | 27.4 | 20.5 | 21.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.1 | 35.8 | 38.9 | 39.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
